Alnylam Pharmaceuticals Statistics
Total Valuation
ALNY has a market cap or net worth of $31.76 billion. The enterprise value is $31.71 billion.
Important Dates
The next estimated earnings date is Thursday, February 13, 2025, before market open.
| Earnings Date | Feb 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ALNY has 128.98 million shares outstanding. The number of shares has increased by 1.97% in one year.
| Current Share Class | 128.98M |
| Shares Outstanding | 128.98M |
| Shares Change (YoY) | +1.97% |
| Shares Change (QoQ) | +1.47% |
| Owned by Insiders (%) | 0.36% |
| Owned by Institutions (%) | 97.20% |
| Float | 128.43M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 14.90 |
| Forward PS | 13.08 |
| PB Ratio | n/a |
| P/TBV Ratio | 981.77 |
| P/FCF Ratio | 1,977.47 |
| P/OCF Ratio | 561.65 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 15.14 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 1,974.11 |
Financial Position
The company has a current ratio of 2.75, with a Debt / Equity ratio of 84.26.
| Current Ratio | 2.75 |
| Quick Ratio | 2.57 |
| Debt / Equity | 84.26 |
| Debt / EBITDA | n/a |
| Debt / FCF | 169.72 |
| Interest Coverage | -1.40 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -2.92% |
| Return on Capital (ROIC) | -4.47% |
| Revenue Per Employee | $997,521 |
| Profits Per Employee | -$158,221 |
| Employee Count | 2,100 |
| Asset Turnover | 0.52 |
| Inventory Turnover | 3.57 |
Taxes
In the past 12 months, ALNY has paid $11.16 million in taxes.
| Income Tax | 11.16M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +31.35% in the last 52 weeks. The beta is 0.34, so ALNY's price volatility has been lower than the market average.
| Beta (5Y) | 0.34 |
| 52-Week Price Change | +31.35% |
| 50-Day Moving Average | 248.92 |
| 200-Day Moving Average | 228.99 |
| Relative Strength Index (RSI) | 50.98 |
| Average Volume (20 Days) | 654,165 |
Short Selling Information
The latest short interest is 3.35 million, so 2.59% of the outstanding shares have been sold short.
| Short Interest | 3.35M |
| Short Previous Month | 3.49M |
| Short % of Shares Out | 2.59% |
| Short % of Float | 2.61% |
| Short Ratio (days to cover) | 5.82 |
Income Statement
In the last 12 months, ALNY had revenue of $2.09 billion and -$332.26 million in losses. Loss per share was -$2.62.
| Revenue | 2.09B |
| Gross Profit | 1.79B |
| Operating Income | -188.13M |
| Pretax Income | -61.70M |
| Net Income | -332.26M |
| EBITDA | -132.15M |
| EBIT | -188.13M |
| Loss Per Share | -$2.62 |
Full Income StatementBalance Sheet
The company has $2.78 billion in cash and $2.73 billion in debt, giving a net cash position of $54.04 million or $0.42 per share.
| Cash & Cash Equivalents | 2.78B |
| Total Debt | 2.73B |
| Net Cash | 54.04M |
| Net Cash Per Share | $0.42 |
| Equity (Book Value) | 32.35M |
| Book Value Per Share | 0.25 |
| Working Capital | 2.13B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $56.56 million and capital expenditures -$40.49 million, giving a free cash flow of $16.06 million.
| Operating Cash Flow | 56.56M |
| Capital Expenditures | -40.49M |
| Free Cash Flow | 16.06M |
| FCF Per Share | $0.12 |
Full Cash Flow StatementMargins
Gross margin is 85.37%, with operating and profit margins of -8.98% and -15.86%.
| Gross Margin | 85.37% |
| Operating Margin | -8.98% |
| Pretax Margin | -15.33% |
| Profit Margin | -15.86% |
| EBITDA Margin | -6.31% |
| EBIT Margin | -8.98% |
| FCF Margin | 0.77% |
Dividends & Yields
ALNY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.97% |
| Shareholder Yield | -1.97% |
| Earnings Yield | -1.05% |
| FCF Yield | 0.05% |
Dividend DetailsAnalyst Forecast
The average price target for ALNY is $299.09, which is 21.45% higher than the current price. The consensus rating is "Buy".
| Price Target | $299.09 |
| Price Target Difference | 21.45% |
| Analyst Consensus | Buy |
| Analyst Count | 24 |
| Revenue Growth Forecast (5Y) | 24.04% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ALNY has an Altman Z-Score of 2 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2 |
| Piotroski F-Score | 4 |